Search details
1.
Predicting prostate cancer progression with a Multi-lncRNA expression-based risk score and nomogram integrating ISUP grading.
Noncoding RNA Res
; 9(2): 612-623, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38576998
2.
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
Lancet Reg Health Am
; 27: 100607, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37808936
3.
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study.
Lancet Reg Health Am
; 13: 100316, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35872665
4.
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
BMJ
; 379: e073070, 2022 11 30.
Article
in English
| MEDLINE | ID: mdl-36450402
5.
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
EClinicalMedicine
; 40: 101126, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34541480
6.
SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.
iScience
; 23(10): 101585, 2020 Oct 23.
Article
in English
| MEDLINE | ID: mdl-32989429
Results
1 -
6
de 6
1
Next >
>>